Persistent generation of thrombin after acute myocardial infarction.
- 1 May 1992
- journal article
- abstracts
- Published by Wolters Kluwer Health in Arteriosclerosis and Thrombosis: A Journal of Vascular Biology
- Vol. 12 (5) , 548-553
- https://doi.org/10.1161/01.atv.12.5.548
Abstract
During the acute phase of myocardial infarction, the generation of thrombin is reflected in the sudden rise of fibrinopeptide A (FPA) and the thrombin-antithrombin III (TAT) complex in blood. We have systematically determined the FPA and TAT plasma concentrations over a period of 14 days after acute myocardial infarction in 100 patients. Mean levels of both thrombin markers were the highest on admission, remained elevated over the following few days, and then gradually declined after day 5. Still, by the end of the first week two thirds of the patients had distinctly elevated TAT and FPA levels, and by the end of the second week such an abnormality was present in half of them. Continuous intravenous heparin infusion at a dose of 20,000 units/day, administered for 1 week to patients who had either received (n = 21) or not received (n = 17) streptokinase, led to a significant depression (p less than 0.05) of thrombin markers over the first 48 hours, an effect that did not persist over the subsequent days of treatment. In patients not assigned to heparin treatment, those in heart failure had significantly (p less than 0.05) higher mean TAT and FPA values on days 3, 5, and 7 compared with patients in whom heart failure was absent. Infarct extension, pulmonary embolism, and death were also associated with a rise in one or both thrombin markers, often preceding the onset of clinical symptoms. Thrombinogenesis was not accompanied by changes in mean plasma concentrations of prothrombin, antithrombin III, or alpha 2-macroglobulin.(ABSTRACT TRUNCATED AT 250 WORDS)Keywords
This publication has 18 references indexed in Scilit:
- Comparison of thrombin-antithrombin complex (TAT) levels and fibrinopeptide A following thrombin incubation of human plasma using hirudin as an inhibitor of TAT formationThrombosis Research, 1991
- Platelet Heterogeneity and Coronary Artery ThrombosisPlatelets, 1991
- Arachidonic Acid-induced Platelet Aggregation ex vivo in Patients with Acute Ischaemic Heart DiseasePlatelets, 1991
- Conjunctive Antithrombotic and Thrombolytic Therapy for Coronary-Artery OcclusionNew England Journal of Medicine, 1990
- Activation of coagulation and fibrinolysis during surgery, analyzed by molecular markersThrombosis Research, 1990
- A comparative evaluation of assays for markers of activated coagulation and/or fibrinolysis: thrombin–antithrombin complex, D-dimer and fibrinogen/fibrin fragment E antigenBritish Journal of Haematology, 1990
- Indices of Hypercoagulation in Cancer as Compared with Those in Acute Inflammation and Acute InfarctionPathophysiology of Haemostasis and Thrombosis, 1990
- D-Dimer and TAT Measurement in Patients with Deep Venous Thrombosis: Utility in Diagnosis and Judgement of Anticoagulant Treatment EffectivenessThrombosis and Haemostasis, 1990
- Paradoxic elevation of fibrinopeptide A after streptokinase: Evidence for continued thrombosis despite intense fibrinolysisJournal of the American College of Cardiology, 1987
- Fibrinopeptide a (FPA) in patients with acute myocardial infarctionThrombosis Research, 1979